Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 06-2008 | 12-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -9,240 | N/A | -24,930 | N/A |
| Depreciation Amortization | N/A | 30 | N/A | 100 | N/A |
| Other Working Capital | N/A | -1,430 | N/A | -290 | N/A |
| Other Operating Activity | 0 | 70 | 0 | 3,670 | 0 |
| Operating Cash Flow | $N/A | $-10,570 | $N/A | $-21,450 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 320 | N/A | 240 | N/A |
| Other Investing Activity | 0 | 10,590 | 0 | 10,390 | 0 |
| Investing Cash Flow | $N/A | $10,910 | $N/A | $10,630 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 210 | 0 | 8,790 | 0 |
| Financing Cash Flow | $N/A | $210 | $N/A | $8,790 | $N/A |
| Beginning Cash Position | N/A | 2,370 | N/A | 4,400 | N/A |
| End Cash Position | N/A | 2,920 | N/A | 2,370 | N/A |
| Net Cash Flow | $N/A | $540 | $N/A | $-2,020 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -10,570 | N/A | -21,450 | N/A |
| Free Cash Flow | 0 | -10,570 | 0 | -21,450 | 0 |